This can lead to muscle loss, fatigue, and an overall feeling of weakness, undermining the very goal of improving metabolic health
HOW TO CHOOSE Semaglutide might be a better fit if: You want the medication with the longest track record (available since 2017) Your insurance covers it (semaglutide has broader insurance coverage currently) You've tried tirzepatide and experienced intolerable side effects You prefer an oral option (Rybelsus is available as a daily pill, though the injectable form is more effective for weight loss) Tirzepatide might be a better fit if: You want the highest average weight loss based on clinical data You have significant insulin resistance or type 2 diabetes (the dual mechanism may provide better blood sugar control) Semaglutide wasn't effective enough at maximum dose You want to maximize results and the cost difference isn't a barrier The truth: Both work well
Anyone with heart, kidney or circulation problems should check with their doctor first, since fluid and electrolyte loads carry more risk for them
Cultures were pulse-labeled with 10 M BrdU (a nucleoside analog that competes with thymidine for incorporation into DNA) in DMEM-10% HS for the final 2-h period of 48-h in culture, followed by immunocytochemistry for detection of BrdU using G3G4 anti-BrdU mAb (1:100 dilution) and HRP-conjugated anti-mouse IgG Ab (1:500 dilution)
However, some of the drugs anti-inflammatory effects start even before meaningful weight loss is achieved